Online now for the #AACR25 session on Advances in #KRAS Biology in PDAC by session speaker Andrew Aguirre: Response and Resistance to RAS inhibition in Cancer brnw.ch/21wSgTw

So proud of presenting our most recent results today at ##AACR25! Fantastic major symposium on KRAS targeting with legends Frank Mccormick and Piro Lito! AACR KRASKickers Johns Hopkins Kimmel Cancer Center Johns Hopkins Medicine

More on RAS targeting! Our stellar postdoc Tessa Seale presented her project on RAS blockade in AML and CMML at #AACR25. Hematological malignancies are also frequently driven by mutant RAS,we hope to develop RAS targeting in these settings.Great job,Tessa!@AACR Johns Hopkins Medicine

So proud of the amazing Santiago G Borrego, PhD presenting our work at #AACR25! Misale lab is rocking in Chicago! AACR Johns Hopkins Medicine KRASKickers Cancer Discovery #proudPI

Today, the American Association for Cancer Research (AACR) called on Congress to reject the Administration's nearly 40% cut to the NIH budget and allocate a bipartisan funding increase to $51.3 billion for the agency to accelerate progress for patients. brnw.ch/21wSrQk

RAS inhibition in PDAC reveals differences between G12 and Q61 mutants providing implications for the development of anti-RAS therapy in clinic. Our recent work describe these phenomena: shorturl.at/U82wA Johns Hopkins Medicine Break Through Cancer Cancer Discovery KRASKickers

Famtastic memories from the last AACR meeting. Always thankful to Cancer Discovery for this great honor!

Research Saves Lives At Johns Hopkins, we just went live with an expansive website showing the extraordinary value of research, the impact of cuts to research, what's at stake, resources for our research community, etc. Check it out: researchsaveslives.jhu.edu

Look back at #AACR25— Sandra Misale, PhD, receives the 2025 Cancer Discovery Early Career Award. Learn more: brnw.ch/21wTivB Johns Hopkins Medicine Johns Hopkins Kimmel Cancer Center

Review: Response and Resistance to RAS Inhibition in Cancer brnw.ch/21wU82x By Richard Y. Ebright, MD, PhD, Julien Dilly, Alice T. Shaw, and Andrew J. Aguirre Dana-Farber Harvard Medical School Broad Institute

🎓 Sei pronto a diventare uno dei migliori oncologi del futuro? Scegli Università degli Studi di Milano per la tua #ScuolaDiSpecializzazione in #Oncologia: ✅ Formazione d'eccellenza 🌍 Visione internazionale 🏆 UnIMI: dove nascono i migliori specialisti. #Oncologia ESMO - Eur. Oncology AIOM